DAL vs PRLD · P/E 12, rev $61.64B vs rev $6.5M
Delta Air Lines Inc (DAL) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the DAL and PRLD stock pages for the full models.
Not investment advice.